These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4007224)

  • 1. Continuous subcutaneous infusion of glucagon by portable pump in non beta cell tumor hypoglycemia.
    Houlbert D; Altman JJ; Lageron A; Capeau J; Dahan R; Friedberg G; Wassef M; Poffenbarger PL; Segrestaa JM
    Diabete Metab; 1985 Apr; 11(2):125-7. PubMed ID: 4007224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intrathecal morphine on blood glucose, glucagon and tissue glycogen in rat: comparison with the effect of xanthan gum on blood glucose.
    el Daly ES
    J Pharm Belg; 1996; 51(4):195-9. PubMed ID: 8831183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of spontaneous hypoglycemia in inoperable liver cell carcinoma with glucagon].
    Mühe E; Schricker KT; Raithel D
    Dtsch Med Wochenschr; 1969 Sep; 94(36):1781-5. PubMed ID: 4308900
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized.
    Pearson T
    Diabetes Educ; 2008; 34(1):128-34. PubMed ID: 18267999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial hyperinsulinism].
    Lásztity N; Balogh L
    Orv Hetil; 1995 Jul; 136(30):1611-3. PubMed ID: 7637980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intranasal glucagon in the treatment of hypoglycemia. A therapeutic possibility in the future].
    Carstens S; Andersen I
    Ugeskr Laeger; 1994 Jul; 156(30):4339-42. PubMed ID: 8066934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Major hypoglycemia during malaria outburst treated by quinine: importance of glucagon].
    Rasoloherimampiononiaina MR
    Bull Soc Pathol Exot; 2004 Aug; 97(3):175-6. PubMed ID: 15462197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful administration of intranasal glucagon in the out-of-hospital environment.
    Sibley T; Jacobsen R; Salomone J
    Prehosp Emerg Care; 2013; 17(1):98-102. PubMed ID: 22971130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
    Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism.
    Neylon OM; Moran MM; Pellicano A; Nightingale M; O'Connell MA
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1157-61. PubMed ID: 23813352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior exercise and the response to insulin-induced hypoglycemia in the dog.
    Koyama Y; Galassetti P; Coker RH; Pencek RR; Lacy DB; Davis SN; Wasserman DH
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1128-38. PubMed ID: 11934679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.